News GLP-1 Users May Face Optic Nerve Damage Risk in First Year by Medscape • 2025/07/30 • 0 Comments A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, especially with liraglutide and among people without diabetes or obesity. Medscape Medical News